Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Study treatment
DRUG
2 trials
Sponsors
National Cancer Center, Korea
, No sponsors
Conditions
Non-Small-Cell Lung Carcinoma
Papillary Thyroid Cancer 1-4 cm
Phase 1
Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)
NCT01027676
National Cancer Center, Korea
Non-Small-Cell Lung Carcinoma
Start: 2010-06-30
End: 2014-03-31
Target: 50
Updated: 2013-11-14
Unknown Phase
Dutch De-escalation pilot Study
Recruiting
NL-OMON22164
No sponsors
Papillary Thyroid Cancer 1-4 cm
Start: 2020-10-01
Target: 12
Updated: 2024-02-28
Related Papers
Phase I/II study of gefitinib (Iressa®) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer
Cancer Chemotherapy and Pharmacology
2014-12-31
56 citations